Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Sun Pharma Announces U.S. FDA Approval of ILUMYA™

Posted On: 2018-03-21 07:07:19

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today announced that the U.S. Food and Drug Administration (FDA) has approved ILUMYA™ (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ILUMYA™ selectively binds to the p19 subunit of IL-23 and inhibits its interaction with the IL-23 receptor leading to inhibition of the release of pro-inflammatory cytokines and chemokines. ILUMYA™ is administered at a dose of 100 mg by subcutaneous injection every 12 weeks, after the completion of initial doses at weeks 0 and 4. ILUMYA™ is contraindicated in patients with a previous serious hypersensitivity reaction to tildrakizumab or to any of the excipients.

"With the approval of ILUMYA™ and our long-standing commitment in dermatology, we are focused on making a difference for people living with moderate-to-severe plaque psoriasis," said Abhay Gandhi, President and Chief Executive Officer, North America, Sun Pharma. "We are committed to working with all relevant stakeholders to make ILUMYA™ available to appropriate people with plaque psoriasis."

The FDA approval of ILUMYA™ for the treatment of adults with moderate-to-severe plaque psoriasis was supported by data from the pivotal Phase-3 reSURFACE clinical development program. In the two multicenter, randomized, double-blind, placebo-controlled trials (reSURFACE 1 and reSURFACE 2), 926 adult patients were treated with ILUMYA™ (N=616) or placebo (N=310). Results from these studies were published in The Lancet in July 2017, with primary endpoints presented at the 25th European Academy of Dermatology and Venereology (EADV) Congress.

Both Phase-3 studies met the primary efficacy endpoints, demonstrating significant clinical improvement with ILUMYA™ 100 mg compared to placebo when measured by at least 75 percent of skin clearance (Psoriasis Area Sensitivity Index or PASI 75) and Physician's Global Assessment (PGA) score of "clear" or "minimal" at week 12 after two doses.

Of the patients in the reSURFACE 1 study 74 percent (229 patients) achieved 75 percent skin clearance at week 28 after three doses, and 84 percent of patients who continued receiving ILUMYA™ 100 mg maintained PASI 75 at week 64 compared to 22 percent of patients who were re-randomized to placebo. In addition, 69 percent of the patients receiving ILUMYA™ 100 mg who had a PGA score of "clear" or "minimal" at week 28 maintained this response at week 64 compared to 14 percent of patients who were re-randomized to placebo.

Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.504.7 as compared to the previous close of Rs. 508.85. The total number of shares traded during the day was 409209 in over 3190 trades.

The stock hit an intraday high of Rs. 515.8 and intraday low of 502.8. The net turnover during the day was Rs. 208634257.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

JK Tyre & Industries Ltd reports net profit of Rs. 64.24 crores in Q1

Mindtree Ltd posts Q1 net profit of Rs. 158.2 crores

GHCL Ltd Q1 net profit drops to Rs. 61.59 crore

Foseco India Ltd Q2 net profit up at Rs. 8.42 crores

Sasken Technologies Ltd posts surge in Q1 Net Profit to Rs. 28 crores

JM Financial Ltd Q1 net profit up at Rs. 199.06 crores

Mastek Ltd Q1 consolidated PAT surges to Rs. 22.46 crores

Responsive Industries Ltd Q1 net profit zooms to Rs. 16.29 crores

HT Media Ltd reports consolidated Q1 net profit of Rs. 9.14 crore

Ultratech Cement Ltd Q1 net profit falls to Rs. 631.21 crores

NIIT Technologies Ltd Q1 consolidated PAT rises to Rs. 90.4 crore

Bandhan Bank Q1 net profit up 47.5% at Rs. 481.71 crore

Ion Exchange India Ltd calls for board meeting on July 31, 2018

Avenue Supermarts Ltd board to announce Q1 results on July 30, 2018

Optiemus Infracom Ltd to form JV for blockchain based software services

Federal-Mogul Goetze India Ltd board to approve quarterly results on July 31, 2018

IFB Industries Ltd board to announce Q1 results on July 26, 2018

Bandhan Bank Ltd Q1 net profit jumps to Rs. 481.71 crores

Sun Pharma receives U.S. FDA Approval of INFUGEM™ Injection

Tamboli Capital Ltd calls for board meeting on Aug 13, 2018

Thomas Cook India Ltd Launches 'Study Buddy' to leverage the peak student travel season

Quess Corp Ltd board to approve 1st quarter results on July 26, 2018

Samkrg Pistons & Rings Ltd board to consider Q1 results on July 30, 2018

Artemis Global Life Sciences Ltd calls for board meeting on Aug 3, 2018

Nucleus Software announces Q1 FY19 Financial Results

Lakshmi Mills Company Ltd board to consider Q1 results on Aug 13, 2018

Elgi Equipments forms company in Australia

Zydus receives four consecutive ANDA approvals from the USFDA

Jindal Stainless Limited posts 2x jump in Q1 PAT

Reliance Nippon Life Asset Management Ltd board to consider Q1 results on July 25, 2018

CRISIL Ltd announces Q2 CY2018 results

IMFA announces Q1 FY19 results

5paisa Capital - Income for Q1FY19 at Rs. 906 Lakhs

Rallis India Ltd Q1 consolidated PAT higher at Rs. 54.58 crore

Jindal Stainless Ltd Q1 net profit soars to Rs. 90.85 crore

Tata Sponge Iron Ltd Q1 net profit higher at Rs. 45.56 crores

CRISIL Ltd Q2 net profit at Rs. 77.13 crore

Sintex Industries Ltd Q1 PAT up at Rs. 39.12 crores

HDFC AMC IPO to open on July 25, 2018

Nucleus Software Exports Ltd Q1 PAT climbs to Rs. 17.59 crores

Symphony Limited Board to consider First Interim Dividend on July 24, 2018

Acrysil Ltd board to announce Q1 results on July 25, 2018

Udaipur Cement Works Ltd board to approve first quarter results on July 25, 2018

DIAL renews its contract with Majestic Research Services and Solutions Limited

CRISIL Ltd Board declares Second Interim Dividend of Rs. 6 for 2018

TV Today Network Ltd board to announce Q1 results on Aug 9, 2018

Shoppers Stop Ltd closes HomeStop store at Embassy Paragon

JK Paper Ltd board to approve first quarter results on July 31, 2018

Dishman Carbogen Amcis Ltd calls for board meeting on July 25, 2018

Vibrant Global Capital Ltd to further invest in subsidiary





Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2018